Jean-Philippe HERBEUVAL- Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques (LCBPT), Université Paris descartes, Paris, FRA
Host : Marc…
The CIML aims at recruiting up to two team leaders
We are looking for outstanding candidates on a mission to advance knowledge on all aspects of immunology. Applicants should send a CV with a list of publications, a 2-page summary of past research achievement and future projects, and contact information for three referees, before June 30th to Dr. Marc Dalod, to whom informal inquiries may also be adressed.
2nd ICI - CIVIS Summer School
Organoid models in immuno - oncology
July 3 – 7, 2023
CIML - Luminy Campus - Marseille, France
The Institut Cancer et Immunologie (ICI) is pleased to announce the 2nd edition of its Summer School on Organoid Models in Immuno-Oncology in collaboration with the European Civic University CIVIS. It will take place at CIML-July 3-7/23.
Calling European PhD students and Master students for application.
Deadline March 15th
More information Program Registration
An advanced international course
6th course on Immunity and Cancer immunotherapy
June 20 – 23, 2023
Aix-Marseille Université, Palais du Pharo, Marseille
This international course offers 3,5 days of lecture and discussion centered on the biology of immunity and cancer immunotherapy. Conferences are delivered by experts who will present the latest developments in the different fields of immunology, including innate immunity, myeloid and lymphoid cell biology, and the microenvironment’s role in the activation of immunity.
Registration deadline extended to March 31th, 2023
More information and registration
Mauro GAYA, new member of the EMBO Young Investigators Programme
EMBO announces 24 scientists as the newest members of the EMBO Young Investigator Programme. The programme supports excellent group leaders who have been in independent positions for less than four years and have an excellent track record of scientific achievements.
The new EMBO Young Investigators will join the existing network of 135 current and 390 former members of the programme. They will receive financial and practical support for a period of four years, starting in January 2023.
FOR THE 7TH CONSECUTIVE YEAR, ERIC VIVIER AND BERNARD MALISSEN ARE AMONG THE MOST CITED RESEARCHERS IN THE WORLD
Eric VIVIER and Bernard MALISSEN, team leaders at the Marseille-Luminy Immunology Center, are on the 2022 list of the most cited researchers in the world for the seventh time, as in previous editions 2016, 2017, 2018, 2019, 2020 and 2021.
Published annually by the prestigious Clarivate Analytics Company, previously Thomson Reuters, this ranking recognizes authors of the most frequently cited publications in the scientific community.
A recognition mark that rewards the value of their discoveries and the exceptional research influence in their scientific field.
At the crossroads of biology and medicine, immunology is a scientific discipline that focuses on the operating mechanisms of the immune system. Appeared early in the evolution, this system enables living organisms to defend themselves against pathogens or their own components when they are altered. It involves a large number of cells whose capacity for cooperation, recognition and memory are far from having revealed all their secrets.
CIML ERC GRANTS
ERC "Advanced Grants"
Bernard Malissen – 2018 – Basilic Projet
Michael Sieweke – 2016 – Macrophage Aging and Rejuvenation
Eric Vivier – 2016 – Targeting Innate Lymphoid Cells
Bernard Malissen – 2012 – Integrative biology of T cells and dendritic cells in vivo
Eric Vivier – 2010 – The Immune Function of Natural Killer
ERC "Consolidator Grants"
Sophie Ugolini – 2014 – Neural regulation of immunity
Marc Bajénoff – 2014 – Immunobiology of lymphoid stromal cells
ERC "Starting Grants"
Mauro Gaya - 2022 - Outlining the role of IgA in Memory Instruction
Réjane Rua - 2020 - Spatiotemporal control of neuroinfection by meningeal macrophages
Marc Dalod – 2011 – Harnessing systems immunology to unravel dendritic cell subset biology
Toby Lawrence - 2010 – Targeting tumor associated macrophages in Cancer
ERC "Proof of Concept (PoC) Grant"
Eric Vivier - 2019 - MInfla-Tilc
Discover our close-ups and our video archives.